A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
A CLINICAL TRIAL USING METHYLATION AGE TO EVALUATE CURRENT ANTI-AGING PRACTICES
2020
Proceedings of the 3rd International Conference in celebration of the 85th birthday of professor V.P. Skulachev. Abstract Book
unpublished
Recent advances in the technology of "aging clocks" based on DNA methylation suggest that it may be possible to measure changes in the rate of human aging over periods as short as a year or two. To the extent that methylation (and other biomarkers) are valid surrogates for biological age, the testing of antiaging interventions has thus become radically cheaper, faster, and more practical. Together with colleagues at UCLA, I have initiated a clinical trial to evaluate some of the most popular
doi:10.30826/homosapiens-2020-19
fatcat:qntj3nmhbbdkxbwopciebnfy24